Developer docs
API playgroundTry for free, no card

Search company profiles

Phase Genomics

Full company profile

uuid0000eod

Namestring
Phase Genomics
Legal namestring
Phase Genomics, Inc.
Company typeenum
Private
Founded yearint
2015
Descriptiontext

Phase Genomics is a Seattle-based, privately held biotechnology company founded in 2015 that develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing applications spanning metagenomics, plant and animal genomics, cytogenetics, and cancer diagnostics. Its core platform captures physical interactions between DNA sequences co-located in cells in vivo, enabling chromosome-scale genome assemblies, culture-free metagenome deconvolution, and host attribution of mobile genetic elements without reliance on reference databases or statistical assumptions. The company sells the ProxiMeta platform for metagenome deconvolution (with sample-type-specific kits and an included cloud-based Explorer analysis environment) and the Proximo platform for genome scaffolding across human, animal, plant, fungal, and microbial sample types. Complementary algorithms include FALCON-Phase (co-developed with PacBio for haplotype phasing) and ProxiPhage (for viral genome reconstruction and host attribution), with newer programs OncoTerra (AI-based cancer diagnostics) and CytoTerra (cytogenomics) extending into clinical-adjacent verticals.

The company operates a hybrid business model combining product-led kit sales through its website, customized fee-for-service projects (library prep, sequencing, and bioinformatics), and grant-funded R&D. Pricing is not publicly disclosed; ProxiMeta kits include free cloud-based analysis while Proximo kits are sold with or without analysis services and service projects are quoted individually. Distribution is primarily direct in the US with an international distributor network covering 11 countries across APAC, Oceania, and Europe (e.g., Sapphire Bioscience, Nucleus Biotech, Filgen, Phyzen). QIAGEN distributes Hi-C epigenetics products in the US under a 2020 channel partnership. Customers are predominantly academic and research institutions (named users include Auburn/HudsonAlpha, Iowa State, BYU, University of Bern, and Ohio State) alongside biopharmaceutical firms, with products labeled "For Research Use Only." Capital formation has been almost entirely non-dilutive, with cumulative disclosed grant funding exceeding $16 million from NIH, the Bill & Melinda Gates Foundation, and the National Cancer Institute between 2017 and 2024. The company employs 11-50 people and is led by founder/CEO Ivan Liachko, CTO Shawn Sullivan, COO Kayla Young, VP R&D Stephen Eacker, and CBO David Shoultz (appointed October 2024).

Short descriptiontext

Phase Genomics develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing, selling Hi-C kits, cloud-based analysis, and custom services to academic researchers and biopharmaceutical firms for metagenomics, genome scaffolding, and cytogenetics applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSeattle, United States
HQ citystring
Seattle
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
Hi-C proximity ligation, metagenome deconvolution, genome scaffolding kits, haplotype phasing, library preparation reagents
Industry3 codes
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)
NAICS code3 codes
  • In-Vitro Diagnostic Substance Manufacturing325413
  • Medical Laboratories621511
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • In Vitro & In Vivo Diagnostic Substances2835
  • Services-Medical Laboratories8071
Product category
Genomics Research Reagents and Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Hi-C Kit Sales
TypeOne Time License
Description

Sale of proximity ligation library preparation kits (Proximo and ProxiMeta) for various sample types including human, animal, plant, fungi, and microbes. Kits include reagents for library prep but do not include sequencing costs.

phasegenomics.com
2Analysis Service Projects
TypeProfessional Services
Description

Customized service projects including Proximity ligation and/or shotgun library prep, Hi-C library QC, NGS services, FALCON-Phase haplotype phasing, 3D conformational mapping, and de novo genome assembly and annotation.

phasegenomics.com
3Cloud-based Analysis Platform
TypeSubscription Recurring
Description

ProxiMeta kits include free cloud-based ProxiMeta Analysis on the web-based platform. Proximo analysis services available separately for genome scaffolding projects.

phasegenomics.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Pricing details3 tiers
1ProxiMeta 8-sample kit with included analysis
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

ProxiMeta Hi-C kit includes all specialized reagents, dual-indexed library prep, and free online ProxiMeta Metagenome Deconvolution analysis.

phasegenomics.com
2Proximo Hi-C 2-pack kits
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Proximo Hi-C kits for Animals, Plants, Fungi or Microbes include reagents for two library preps. Human sample kit provides four library preps. Sequencing and analysis sold separately.

phasegenomics.com
3Customized full-service projects
ModelOtherBilling cadenceMulti-year contract
Notes

Customized service projects including library prep, sequencing, and data analysis tailored to customer needs. Pricing by quote.

phasegenomics.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1ProxiMeta
Description

Metagenome Deconvolution Platform for microbiome research, enabling high-quality genome assembly from complex microbial communities without culturing

phasegenomics.com
+5 more records
Core offering1 text field

Phase Genomics develops and sells proprietary proximity ligation (Hi-C) library preparation kits and bioinformatics platforms that enable ultra-long-range genome sequencing for metagenome deconvolution, chromosome-scale genome scaffolding, haplotype phasing, and cytogenomics. Its core offerings include the Proximo and ProxiMeta kit platforms (with sample-type-specific formulations), cloud-based ProxiMeta Explorer analysis, and customized end-to-end service projects for academic, biopharmaceutical, and agricultural biotechnology customers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Detects organisms at 0.02% abundance (1 in 5,000 cells) in complex samples
+3 more records
Product overview1 text field

Phase Genomics offers a platform-plus-products architecture centered on ultra-long-range genome sequencing technology powered by proximity ligation (Hi-C). The core products include the ProxiMeta™ Platform for metagenome deconvolution and the Proximo™ Platform for genome scaffolding, both supported by sample-type-specific Hi-C library preparation kits. These platforms are complemented by the FALCON-Phase haplotype phasing algorithm (co-developed with PacBio), the ProxiPhage algorithm for viral analysis, and the cloud-based ProxiMeta Explorer for data analysis. In June 2025, the company expanded its offerings with ProxiMeta Starter and Elite Bundles to provide tiered access to genome-resolved metagenomics.

Product and service13 records
1ProxiMeta Platform
CategoryMetagenomics platform
Description

A complete sample-to-insights metagenome deconvolution platform that combines proximity ligation (Hi-C) data with shotgun sequencing to assemble high-quality metagenomes and associate mobile genetic elements (plasmids, phages, antibiotic resistance genes) with their microbial hosts without culturing. Designed for microbiome researchers, infectious disease investigators, and biopharmaceutical groups needing strain-level resolution of complex microbial communities.

2Proximo Platform
CategoryGenome scaffolding platform
Description

Genome scaffolding platform that employs proximity ligation (Hi-C) data to orient and order contigs into chromosome-scale, reference-quality genome assemblies. Available in five sample-type-specific kit formulations (human, animal, plant, fungal, microbe) and used by researchers building reference genomes, resolving haplotypes, and detecting structural variants across organisms.

3Proximo Hi-C Kit (Human)
CategoryLibrary preparation kit
Description

Proximity ligation library preparation kit optimized for human samples, including reagents for four library preps and dual-indexed libraries compatible with Illumina and Element sequencing platforms. Used by human genomics, cytogenetics, and clinical research laboratories for chromosome-scale genome assembly and haplotype phasing.

4Proximo Hi-C Kit (Animal)
CategoryLibrary preparation kit
Description

Proximity ligation library preparation kit optimized for animal samples, including reagents for two library preps and dual-indexed libraries compatible with Illumina and Element sequencing platforms. Designed for various vertebrate and invertebrate tissue types used in animal genomics and reference genome projects.

5Proximo Hi-C Kit (Plant)
CategoryLibrary preparation kit
Description

Proximity ligation library preparation kit optimized for plant samples, including additional wash steps for samples rich in polyphenols and reagents for two library preps. Designed for plant genomics, polyploid crop improvement, and reference genome assembly of species with complex genomes.

6Proximo Hi-C Kit (Fungal)
CategoryLibrary preparation kit
Description

Proximity ligation library preparation kit optimized for fungal samples, including reagents for two library preps and designed to handle challenging fungal genomic elements such as repeats and structural variants. Used by fungal genomics and fungal pathogen researchers.

7Proximo Hi-C Kit (Microbe)
CategoryLibrary preparation kit
Description

Proximity ligation library preparation kit optimized for microbial samples, including reagents for two library preps and designed for bacterial and archaeal genome applications. Used by microbiology, environmental genomics, and microbiome researchers.

8FALCON-Phase
CategoryBioinformatics algorithm
Description

Haplotype phasing algorithm co-developed with PacBio that combines Hi-C data with long-read sequencing (FALCON-Unzip or purge_haplotigs) to produce two true phased sets of contigs for diploid organisms, achieving >96% contig phasing accuracy. Available through joint commercialization with PacBio and used by researchers building diploid reference genomes.

9ProxiPhage
CategoryBioinformatics algorithm
Description

Algorithm available through the ProxiMeta platform that augments metagenomic analysis with Hi-C linkage information to enable specific and sensitive host attribution of DNA viruses (phages) and reconstructs higher-quality bacterial and viral genomes without culturing. Used by microbiome, phage, and infectious disease researchers.

10ProxiMeta Explorer
CategoryCloud analysis platform
Description

Interactive, cloud-based genome-resolved metagenomic analysis platform included free with ProxiMeta kit purchases. Enables taxonomic annotation, abundance calculations, customizable analyses, and genome tracking across samples for researchers performing metagenomic studies.

11ProxiMeta Starter Bundle
CategoryProduct bundle
Description

Entry-level product bundle launched in June 2025 to expand access to genome-resolved metagenomics research, designed for researchers beginning metagenomic studies with comprehensive ProxiMeta kit and analysis capabilities.

12ProxiMeta Elite Bundle
CategoryProduct bundle
Description

Premium product bundle launched in June 2025 offering comprehensive access to deep metagenomic research capabilities for advanced researchers, including expanded ProxiMeta kit reagents and cloud analysis features.

13Customized Genomic Analysis Service Projects
CategoryGenomic services
Description

Customized full-service projects including proximity ligation and/or shotgun library preparation, Hi-C library QC, NGS sequencing services, FALCON-Phase haplotype phasing, 3D conformational mapping, and de novo genome assembly and annotation. Sold by quote and tailored to enterprise and academic customer needs.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2020-10-29
Description

Strategic partnership to bring Hi-C epigenetics solutions to the US market. QIAGEN distributes Phase Genomics proximity ligation products.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2018-10-08
Description

Co-development of FALCON-Phase software that combines PacBio long-read sequencing with Hi-C data to produce highly contiguous phased diploid genome assemblies. Joint commercialization of the software.

3Integrated Sciences Pty Ltd
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Australia.

phasegenomics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Australia and New Zealand.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Austria, Germany, and Switzerland.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Japan.

7Phyzen
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Korea.

phasegenomics.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Malaysia and Singapore.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Authorized distributor for Phase Genomics products in Indonesia.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Dovetail, now part of Cantata Bio, is the original commercializer of Hi-C proximity ligation kits for genome scaffolding and is Phase Genomics' most direct competitor in metagenome deconvolution and de novo assembly applications.

TypeDirect peer
Description

10x Genomics offers linked-read and single-cell kits that compete with Hi-C-based scaffolding and metagenomic phasing for similar academic and biopharma customers.

TypeDirect peer
Description

Bionano's optical genome mapping is an alternative approach to chromosome-scale scaffolding and structural variant detection, serving the same cytogenomics and de novo assembly workflows as Proximo.

TypeBroad incumbent
Description

PacBio is both a sequencing-platform partner (co-developer of FALCON-Phase with Phase Genomics) and a broader incumbent whose long-read chemistry increasingly competes with Hi-C for assembly and phasing use cases.

TypeBroad incumbent
Description

Illumina is the dominant short-read sequencing platform onto which Phase Genomics' kits are designed to run; it is also a broad incumbent that could launch competing proximity-ligation or linked-read chemistries.

TypeBroad incumbent
Description

QIAGEN is a US distribution partner for Phase Genomics' Hi-C products and also a broad sample-prep incumbent whose catalog of nucleic acid reagents overlaps with kit-based genomic workflows.

TypeBroad incumbent
Description

Oxford Nanopore offers long-read sequencing as an alternative platform to the Hi-C + short-read or Hi-C + PacBio workflows Phase Genomics supports, particularly for de novo assembly and structural variant detection.

TypeEmerging player
Description

Element is an emerging sequencing-platform vendor whose AVITI system is explicitly supported by Proximo kits, positioning it as both a complementary platform and a potential competitor in library-prep ecosystems.

TypeBroad incumbent
Description

Bio-Rad is a broad life-science tools and reagents incumbent with droplet-based and ddPCR technologies that intersect with Phase Genomics' sample-prep and genomic-analysis workflows in academic and clinical research.

TypeEmerging player
Description

KromaTiD develops cytogenomic and chromatin-conformation tools that overlap with Phase Genomics' CytoTerra platform, targeting similar structural-variant and chromosomal-abnormality applications.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Phase Genomics

Genomics Research Reagents and Servicesphasegenomics.com

Phase Genomics develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing, selling Hi-C kits, cloud-based analysis, and custom services to academic researchers and biopharmaceutical firms for metagenomics, genome scaffolding, and cytogenetics applications.

What Phase Genomics does

Phase Genomics is a Seattle-based, privately held biotechnology company founded in 2015 that develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing applications spanning metagenomics, plant and animal genomics, cytogenetics, and cancer diagnostics. Its core platform captures physical interactions between DNA sequences co-located in cells in vivo, enabling chromosome-scale genome assemblies, culture-free metagenome deconvolution, and host attribution of mobile genetic elements without reliance on reference databases or statistical assumptions. The company sells the ProxiMeta platform for metagenome deconvolution (with sample-type-specific kits and an included cloud-based Explorer analysis environment) and the Proximo platform for genome scaffolding across human, animal, plant, fungal, and microbial sample types. Complementary algorithms include FALCON-Phase (co-developed with PacBio for haplotype phasing) and ProxiPhage (for viral genome reconstruction and host attribution), with newer programs OncoTerra (AI-based cancer diagnostics) and CytoTerra (cytogenomics) extending into clinical-adjacent verticals.

The company operates a hybrid business model combining product-led kit sales through its website, customized fee-for-service projects (library prep, sequencing, and bioinformatics), and grant-funded R&D. Pricing is not publicly disclosed; ProxiMeta kits include free cloud-based analysis while Proximo kits are sold with or without analysis services and service projects are quoted individually. Distribution is primarily direct in the US with an international distributor network covering 11 countries across APAC, Oceania, and Europe (e.g., Sapphire Bioscience, Nucleus Biotech, Filgen, Phyzen). QIAGEN distributes Hi-C epigenetics products in the US under a 2020 channel partnership. Customers are predominantly academic and research institutions (named users include Auburn/HudsonAlpha, Iowa State, BYU, University of Bern, and Ohio State) alongside biopharmaceutical firms, with products labeled "For Research Use Only." Capital formation has been almost entirely non-dilutive, with cumulative disclosed grant funding exceeding $16 million from NIH, the Bill & Melinda Gates Foundation, and the National Cancer Institute between 2017 and 2024. The company employs 11-50 people and is led by founder/CEO Ivan Liachko, CTO Shawn Sullivan, COO Kayla Young, VP R&D Stephen Eacker, and CBO David Shoultz (appointed October 2024).

Phase Genomics firmographics

Firmographics
Name
Phase Genomics
Legal name
Phase Genomics, Inc.
Website
https://phasegenomics.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
Phase Genomics develops proximity ligation (Hi-C) technology for ultra-long-range genome sequencing, selling Hi-C kits, cloud-based analysis, and custom services to academic researchers and biopharmaceutical firms for metagenomics, genome scaffolding, and cytogenetics applications.
Ownership category
akta.pro rank

Phase Genomics industry classification

Industry
Product category
Genomics Research Reagents and Services
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGAIAF
Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays)
SECONDARYHLAGAEAD
Genomics & Molecular Diagnostics (Trial Support)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
SECONDARYHLAAALAD
Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics)

Keywords

  • Hi-C proximity ligation
  • Metagenome deconvolution
  • Genome scaffolding kits
  • Haplotype phasing
  • Library preparation reagents

Where Phase Genomics is headquartered

Location

Headquarters

HQ city
Seattle
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Phase Genomics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Hi-C Kit Sales: Sale of proximity ligation library preparation kits (Proximo and ProxiMeta) for various sample types including human, animal, plant, fungi, and microbes. Kits include reagents for library prep but do not include sequencing costs.
  2. Analysis Service Projects: Customized service projects including Proximity ligation and/or shotgun library prep, Hi-C library QC, NGS services, FALCON-Phase haplotype phasing, 3D conformational mapping, and de novo genome assembly and annotation.
  3. Cloud-based Analysis Platform: ProxiMeta kits include free cloud-based ProxiMeta Analysis on the web-based platform. Proximo analysis services available separately for genome scaffolding projects.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goProxiMeta 8-sample kit with included analysis
One time/ perpetual licensePay-as-you-goProximo Hi-C 2-pack kits
OtherMulti-year contractCustomized full-service projects

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Phase Genomics product offering

Product offering

Core offering

Phase Genomics develops and sells proprietary proximity ligation (Hi-C) library preparation kits and bioinformatics platforms that enable ultra-long-range genome sequencing for metagenome deconvolution, chromosome-scale genome scaffolding, haplotype phasing, and cytogenomics. Its core offerings include the Proximo and ProxiMeta kit platforms (with sample-type-specific formulations), cloud-based ProxiMeta Explorer analysis, and customized end-to-end service projects for academic, biopharmaceutical, and agricultural biotechnology customers.

Product overview

Phase Genomics offers a platform-plus-products architecture centered on ultra-long-range genome sequencing technology powered by proximity ligation (Hi-C). The core products include the ProxiMeta™ Platform for metagenome deconvolution and the Proximo™ Platform for genome scaffolding, both supported by sample-type-specific Hi-C library preparation kits. These platforms are complemented by the FALCON-Phase haplotype phasing algorithm (co-developed with PacBio), the ProxiPhage algorithm for viral analysis, and the cloud-based ProxiMeta Explorer for data analysis. In June 2025, the company expanded its offerings with ProxiMeta Starter and Elite Bundles to provide tiered access to genome-resolved metagenomics.

Differentiator

Problem solved

Functional benefit

Brands

  • ProxiMeta: Metagenome Deconvolution Platform for microbiome research, enabling high-quality genome assembly from complex microbial communities without culturing
  • Proximo
  • CytoTerra
  • FALCON-Phase
  • OncoTerra
  • ProxiPhage

Products and services

  • ProxiMeta Platform A complete sample-to-insights metagenome deconvolution platform that combines proximity ligation (Hi-C) data with shotgun sequencing to assemble high-quality metagenomes and associate mobile genetic elements (plasmids, phages, antibiotic resistance genes) with their microbial hosts without culturing. Designed for microbiome researchers, infectious disease investigators, and biopharmaceutical groups needing strain-level resolution of complex microbial communities.
  • Proximo Platform Genome scaffolding platform that employs proximity ligation (Hi-C) data to orient and order contigs into chromosome-scale, reference-quality genome assemblies. Available in five sample-type-specific kit formulations (human, animal, plant, fungal, microbe) and used by researchers building reference genomes, resolving haplotypes, and detecting structural variants across organisms.
  • Proximo Hi-C Kit (Human) Proximity ligation library preparation kit optimized for human samples, including reagents for four library preps and dual-indexed libraries compatible with Illumina and Element sequencing platforms. Used by human genomics, cytogenetics, and clinical research laboratories for chromosome-scale genome assembly and haplotype phasing.
  • Proximo Hi-C Kit (Animal) Proximity ligation library preparation kit optimized for animal samples, including reagents for two library preps and dual-indexed libraries compatible with Illumina and Element sequencing platforms. Designed for various vertebrate and invertebrate tissue types used in animal genomics and reference genome projects.
  • Proximo Hi-C Kit (Plant) Proximity ligation library preparation kit optimized for plant samples, including additional wash steps for samples rich in polyphenols and reagents for two library preps. Designed for plant genomics, polyploid crop improvement, and reference genome assembly of species with complex genomes.
  • Proximo Hi-C Kit (Fungal) Proximity ligation library preparation kit optimized for fungal samples, including reagents for two library preps and designed to handle challenging fungal genomic elements such as repeats and structural variants. Used by fungal genomics and fungal pathogen researchers.
  • Proximo Hi-C Kit (Microbe) Proximity ligation library preparation kit optimized for microbial samples, including reagents for two library preps and designed for bacterial and archaeal genome applications. Used by microbiology, environmental genomics, and microbiome researchers.
  • FALCON-Phase Haplotype phasing algorithm co-developed with PacBio that combines Hi-C data with long-read sequencing (FALCON-Unzip or purge_haplotigs) to produce two true phased sets of contigs for diploid organisms, achieving >96% contig phasing accuracy. Available through joint commercialization with PacBio and used by researchers building diploid reference genomes.
  • ProxiPhage Algorithm available through the ProxiMeta platform that augments metagenomic analysis with Hi-C linkage information to enable specific and sensitive host attribution of DNA viruses (phages) and reconstructs higher-quality bacterial and viral genomes without culturing. Used by microbiome, phage, and infectious disease researchers.
  • ProxiMeta Explorer Interactive, cloud-based genome-resolved metagenomic analysis platform included free with ProxiMeta kit purchases. Enables taxonomic annotation, abundance calculations, customizable analyses, and genome tracking across samples for researchers performing metagenomic studies.
  • ProxiMeta Starter Bundle Entry-level product bundle launched in June 2025 to expand access to genome-resolved metagenomics research, designed for researchers beginning metagenomic studies with comprehensive ProxiMeta kit and analysis capabilities.
  • ProxiMeta Elite Bundle Premium product bundle launched in June 2025 offering comprehensive access to deep metagenomic research capabilities for advanced researchers, including expanded ProxiMeta kit reagents and cloud analysis features.
  • Customized Genomic Analysis Service Projects Customized full-service projects including proximity ligation and/or shotgun library preparation, Hi-C library QC, NGS sequencing services, FALCON-Phase haplotype phasing, 3D conformational mapping, and de novo genome assembly and annotation. Sold by quote and tailored to enterprise and academic customer needs.

Quantifiable outcome

  • Detects organisms at 0.02% abundance (1 in 5,000 cells) in complex samples
  • +3 more outcomes

Companies that use Phase Genomics

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Phase Genomics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature5 records

Phase Genomics partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered major, core and minor.

  • QIAGENmajorChannel Partner/ Reseller/ Distributor · 29 October 2020Strategic partnership to bring Hi-C epigenetics solutions to the US market. QIAGEN distributes Phase Genomics proximity ligation products.
  • Pacific Biosciences (PacBio)coreTechnology or Integration · 8 October 2018Co-development of FALCON-Phase software that combines PacBio long-read sequencing with Hi-C data to produce highly contiguous phased diploid genome assemblies. Joint commercialization of the software.
  • Integrated Sciences Pty LtdminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Australia.
  • Sapphire BioscienceminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Australia and New Zealand.
  • Nucleus Biotech GmbHminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Austria, Germany, and Switzerland.
  • Filgen, Inc.minorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Japan.
  • PhyzenminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Korea.
  • Genosys Inc./Total Genomics SolutionminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Malaysia and Singapore.
  • SciencewerkeminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Phase Genomics products in Indonesia.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Phase Genomics competitors and assessment

Company assessment

Direct peers

  • Dovetail Genomics (Cantata Bio): Dovetail, now part of Cantata Bio, is the original commercializer of Hi-C proximity ligation kits for genome scaffolding and is Phase Genomics' most direct competitor in metagenome deconvolution and de novo assembly applications.
  • 10x Genomics: 10x Genomics offers linked-read and single-cell kits that compete with Hi-C-based scaffolding and metagenomic phasing for similar academic and biopharma customers.
  • Bionano Genomics: Bionano's optical genome mapping is an alternative approach to chromosome-scale scaffolding and structural variant detection, serving the same cytogenomics and de novo assembly workflows as Proximo.

Broad incumbents

  • Pacific Biosciences (PacBio): PacBio is both a sequencing-platform partner (co-developer of FALCON-Phase with Phase Genomics) and a broader incumbent whose long-read chemistry increasingly competes with Hi-C for assembly and phasing use cases.
  • Illumina: Illumina is the dominant short-read sequencing platform onto which Phase Genomics' kits are designed to run; it is also a broad incumbent that could launch competing proximity-ligation or linked-read chemistries.
  • QIAGEN: QIAGEN is a US distribution partner for Phase Genomics' Hi-C products and also a broad sample-prep incumbent whose catalog of nucleic acid reagents overlaps with kit-based genomic workflows.
  • Oxford Nanopore Technologies: Oxford Nanopore offers long-read sequencing as an alternative platform to the Hi-C + short-read or Hi-C + PacBio workflows Phase Genomics supports, particularly for de novo assembly and structural variant detection.
  • Bio-Rad Laboratories: Bio-Rad is a broad life-science tools and reagents incumbent with droplet-based and ddPCR technologies that intersect with Phase Genomics' sample-prep and genomic-analysis workflows in academic and clinical research.

Emerging players

  • Element Biosciences: Element is an emerging sequencing-platform vendor whose AVITI system is explicitly supported by Proximo kits, positioning it as both a complementary platform and a potential competitor in library-prep ecosystems.
  • KromaTiD: KromaTiD develops cytogenomic and chromatin-conformation tools that overlap with Phase Genomics' CytoTerra platform, targeting similar structural-variant and chromosomal-abnormality applications.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

Phase Genomics social profiles

Digital presence

Phase Genomics compliance and trust

Trust signal

Compliance1 record

Phase Genomics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Phase Genomics leadership team

Management profile

Number of profiles

Profiles11 records

Phase Genomics funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Phase Genomics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Phase Genomics

What does Phase Genomics do?

Phase Genomics develops and sells proprietary proximity ligation (Hi-C) library preparation kits and bioinformatics platforms that enable ultra-long-range genome sequencing for metagenome deconvolution, chromosome-scale genome scaffolding, haplotype phasing, and cytogenomics. Its core offerings include the Proximo and ProxiMeta kit platforms (with sample-type-specific formulations), cloud-based ProxiMeta Explorer analysis, and customized end-to-end service projects for academic, biopharmaceutical, and agricultural biotechnology customers.

Is Phase Genomics a public or private company?

Phase Genomics is a private company. It is classified as venture growth investor backed and is currently operating.

When was Phase Genomics founded?

Phase Genomics was founded in 2015. It employs 11 to 50 people.

Where is Phase Genomics based?

Phase Genomics is headquartered in Seattle, United States, in the North America region.

How does Phase Genomics make money?

Three revenue lines are on record. Hi-C Kit Sales are the primary driver. The others are analysis Service Projects and cloud-based Analysis Platform.

Who are Phase Genomics's main competitors?

Direct peers on record are Dovetail Genomics (Cantata Bio), 10x Genomics and Bionano Genomics. Broad incumbents are Pacific Biosciences (PacBio), Illumina, QIAGEN, Oxford Nanopore Technologies and Bio-Rad Laboratories. Emerging players are Element Biosciences and KromaTiD.

Does Phase Genomics have an API?

No public API is recorded for Phase Genomics.

What industry is Phase Genomics in?

Phase Genomics's product category is Genomics Research Reagents and Services. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAEAD, Genomics & Molecular Diagnostics (Trial Support). Its NAICS code is 325413 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PhasegenomicsPhase Genomics Launches ProxiMeta™ Starter and Elite Bundles to Expand Access to Genome-Resolved MetagenomicsPhase Genomics announced the launch of ProxiMeta Starter and Elite Bundles to provide streamlined, full-service solutions for genome-resolved metagenomics research. These new product offerings aim to make advanced microbial insights more accessible by combining sequencing, bioinformatics, and scientific support into scalable formats for early-career and experienced researchers.GeekWireTech Moves: Meta leader for Pacific NW steps down; Phase Genomics adds to C-suiteThis article reports on a series of executive personnel changes and leadership transitions within the Pacific Northwest technology sector, including Meta's Paresh Rajwat stepping down as regional head and Phase Genomics appointing David Shoultz as its first chief business officer. Other notable moves include Sana Biotechnology promoting Susan Wyrick to acting CFO following Nathan Hardy's departure, CTL naming Jason Mendenhall as its new CEO, and Microsoft veteran David Willis joining Zensai's board. Additional updates cover leadership shifts at Tech Alliance, Outreach, Accenture, Teal Communications, and academic honors for University of Washington professor Nicola Dell.Pulse 2.0Phase Genomics: $1.5 Million Funding Raised From Bill & Melinda Gates FoundationPhase Genomics announced it received $1.5 million in funding from the Bill & Melinda Gates Foundation to develop a new antimicrobial discovery platform using lysins. The project, which involves a collaboration with Lumen Bioscience, aims to address antibiotic resistance and reduce methane emissions by targeting specific bacteria and archaea.FinSMEsPhase Genomics Raises $1.5M in FundingPhase Genomics raised $1.5 million in funding from the Bill & Melinda Gates Foundation to develop a new antimicrobial discovery platform. The company plans to utilize this capital to harness its global phage database for improving human and environmental health as an alternative to traditional antibiotics.GeekWirePhase Genomics gets $1.5M grant from Gates Foundation to fight cow burp methanePhase Genomics has received a $1.5 million grant from the Bill & Melinda Gates Foundation to develop an antimicrobial discovery platform targeting drug-resistant bacteria and methane-producing microorganisms in cattle. The year-long project will utilize bacteriophages to create lysin-based antibiotics, with Lumen Bioscience collaborating on bioactivity assessments. This funding supports Phase Genomics' goal of providing alternatives to traditional antibiotics while addressing agricultural greenhouse gas emissions.PhasegenomicsPhase Genomics Announces Funding to Accelerate Discovery of New Lysin-Based Precision AntimicrobialsPhase Genomics announced a $1.5 million funding grant from the Bill & Melinda Gates Foundation to develop a new lysin-based precision antimicrobial discovery platform. The initiative, in collaboration with Lumen Bioscience, aims to address antibiotic resistance and reduce methane emissions by leveraging Phase Genomics' proprietary phage atlas. This project focuses on engineering lysins to target specific bacteria like Campylobacter and methanogenic archaea.GlobeNewswireBioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards ProgramBioTech Breakthrough announced its 2023 award winners, recognizing companies across categories like BioPharma, Genomics, and Therapeutics. The program received thousands of nominations from over 12 countries, with winners including SURGE Therapeutics and Phase Genomics.YahooBioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards ProgramBioTech Breakthrough announced its 2023 award winners, recognizing companies across categories like BioPharma, Genomics, and Therapeutics. The program received thousands of nominations from over 12 countries, with winners including SURGE Therapeutics and Phase Genomics.GlobeNewswireBioTechnology Innovators Honored in 3rd Annual BioTech Breakthrough Awards ProgramBioTech Breakthrough announced its 2023 award winners, recognizing companies across BioPharma, Genomics, Therapeutics, and other categories. The program received thousands of nominations from over 12 countries, with winners including SURGE Therapeutics and Phase Genomics.GeekWireWashington state backs AI-driven cancer diagnostics and other startup projectsSeattle-based Phase Genomics secured $2.5 million in new funding to advance its AI-driven OncoTerra 3D genomics platform for detecting chromosomal aberrations in cancer. The investment consists of a $2 million award from the U.S. National Cancer Institute and $500,000 in matching funds from Washington state’s Andy Hill CARE Fund. This funding will support the analysis of tumor samples to develop predictive models for acute myeloid leukemia and colorectal cancer.